Early Assessment of Quadriceps Muscle Recovery by Dynamometry and 3D Ultrasound in Intensive Care Patients Under Invasive Mechanical Ventilation
DYNAMOREA
1 other identifier
observational
100
1 country
1
Brief Summary
Patients in intensive care often develop acquired muscle weakness (ICUAW or Intensive Care Unit Acquired Weakness) due to immobilization and muscle atrophy. Early mobilization can help reduce weakness and improve functional recovery, but practices vary. Muscle strength assessment, particularly using the MRC (Medical Research Council) score, is crucial, though it has precision limitations. Additional methods, such as manual dynamometry and functional scales, are needed to better track muscle recovery. The quadriceps, important for function, requires early evaluation, but there is a lack of specific data in intensive care to predict medium-term functional recovery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Aug 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 24, 2025
CompletedFirst Posted
Study publicly available on registry
July 17, 2025
CompletedStudy Start
First participant enrolled
August 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
November 1, 2026
July 17, 2025
July 1, 2025
1.3 years
June 24, 2025
July 16, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Describe the evolution of quadriceps muscle recovery using manual dynamometry in patients under invasive mechanical ventilation in the ICU.
This study aims to describe the evolution of quadriceps muscle recovery in ICU patients under invasive mechanical ventilation, using manual dynamometry as a measurement tool. The recovery will be assessed periodically throughout the ICU stay to evaluate early muscle strength recovery.
3 months
Description of the evolution of the recovery of the rectus femoris muscle using 3D ultrasound in ICU patients treated with invasive mechanical ventilation.
Change in the volume of the rectus femoris muscle measured by 3D ultrasound.
3 months after ICU discharge
Secondary Outcomes (17)
Estimate the average value of the FMQ
From inclusion to 3 months post-ICU discharge
To study the correlation between FMQ values and other muscular and functional scores on the same day.
From inclusion to 3 months post-ICU discharge
Study the differences in muscle strength between right and left FMQ values on the same day
From inclusion to 3 months post-ICU discharge
Study the correlation between FMQ at inclusion and the time until extubation, when the patient was still intubated at inclusion
From inclusion to the day of extubation, an average of 7 days
Study the correlation between FMQ at inclusion and the ability to achieve verticalization for patients who could stand before ICU discharge
From inclusion to ICU discharge, an average of 10 days
- +12 more secondary outcomes
Study Arms (1)
Patients under invasive mechanical ventilation in the ICU
This group includes patients admitted to the Intensive Care Unit (ICU) at the CHU of Nantes, treated with invasive mechanical ventilation. The study aims to evaluate the early recovery of quadriceps muscle strength in these patients, using non-invasive, pain-free assessment methods. The cohort will consist of approximately 100 patients over one year, with data collected via the medical record and strength measurements performed by physical therapists.
Interventions
Patients will undergo non-invasive assessment of quadriceps muscle strength using manual dynamometry and 3D ultrasound. These assessments will be conducted regularly during their ICU stay to evaluate early recovery. The intervention is part of routine patient care and does not involve additional treatments or procedures.
Eligibility Criteria
The study population includes adults (aged \>18 years) admitted to the ICU and treated with invasive mechanical ventilation for at least 4 days. Participants must be conscious, cooperative, and have an MRC score ≥ 3/5 for "Leg Extension" on either side. Informed consent or no objection is required. Exclusion criteria include pregnancy, neurological disorders, lower limb injuries, or conditions preventing safe participation.
You may qualify if:
- Adults aged \> 18 years
- Hospitalized in an ICU
- Conscious and cooperative patients: ability to respond appropriately to the following commands: open and close eyes, look at me, nod your head, stick out your tongue, raise your eyebrows when I count to five
- MRC score ≥ 3/5 for the "Leg Extension" function on either the left or right side
- Informed consent obtained (no opposition)
You may not qualify if:
- Pregnant or breastfeeding women
- Fracture or amputation of a lower limb
- Acute or chronic brain or spinal cord injury responsible for hemiplegia or paraplegia
- Unstable spinal injury
- Neurodegenerative or chronic neurological disease
- Guillain-Barré Syndrome
- Myasthenia Gravis
- Acute deep vein thrombosis of the lower limbs treated within the last 48 hours
- Pre-existing motor deficit in a lower limb before the ICU stay, of any cause
- Incarcerated or legally protected individuals (guardianship, curatorship)
- Individuals without social protection
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Nantes University Hospital
Nantes, Loire Atlantique, 44300, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 24, 2025
First Posted
July 17, 2025
Study Start
August 1, 2025
Primary Completion (Estimated)
November 1, 2026
Study Completion (Estimated)
November 1, 2026
Last Updated
July 17, 2025
Record last verified: 2025-07